Obesity is associated with an increase in pharmaceutical expenses among university employees.

Obesity is associated with an increase in pharmaceutical expenses among university employees.
复制标题

DOI:
10.1155/2015/298698
复制
发表时间:
2015
期刊:
影响因子:
3.3
通讯作者:
Koplan JP
Koplan JP
中科院分区:
其他
文献类型:
--
作者:
Gazmararian JA;Frisvold D;Zhang K;Koplan JP

文献摘要

被引文献

相似文献

目标。检查与员工肥胖相关的成本,以及与成本增加相关的因素。方法:研究方法。我们使用了来自体育活动和生活方式(PALS)研究的数据,这是一项随机前瞻性设计,评估了三种干预措施,以增加不活跃的非教职员工的体育活动(n=454)。主要暴露变量肥胖(通过身体质量指数衡量)是从面对面的基线调查中获得的。协变量是从基线调查中获得的,包括人口特征和健康状况。基线调查的数据与管理数据相关联,以确定三年的药品、住院、门诊和总医疗保健成本。肥胖者和非肥胖者的平均每月支出使用t检验和两部分多元回归模型进行比较,该模型根据人口统计学和社会经济特征以及健康行为进行了调整。结果。虽然住院和门诊费用与肥胖无关,但肥胖者每年的药品支出比非肥胖者高408美元或87.2%(468美元对876美元),这反映了肥胖者较差的健康行为和健康状况。结论。员工对肥胖相关成本的认识可以刺激雇主投资提供雇主赞助的健康和健康改善计划,以解决肥胖问题。
Objective. To examine costs associated with obesity in an employee population and factors associated with increased costs. Methods. We used data from the Physical Activity and Life Style (PALS) study, a randomized prospective design evaluating three interventions to increase physical activity among physically inactive nonfaculty university employees (n = 454). The primary exposure variable, obesity (measured by body mass index), was obtained from the in-person baseline survey. Covariates were obtained from the baseline survey and included demographic characteristics and health status. Data from the baseline survey was linked with administrative data to determine pharmaceutical, inpatient, outpatient, and total health care costs for three years. Average monthly expenditures for obese and nonobese individuals were compared using t-tests and a two-part multivariate regression model adjusted for demographic and socioeconomic characteristics and health behaviors. Results. Although in-patient and outpatient expenses were not associated with obesity, pharmaceutical expenditures were $408 or 87.2% higher per year ($468 versus $876) for obese individuals than for nonobese individuals, which reflected poorer health behaviors and health status of obese adults. Conclusion. Awareness of the costs associated with obesity among employees can stimulate employers to make the investment in providing employer-sponsored wellness and health improvement programs to address obesity.